Present and future therapeutic strategies for idiopathic oligozoospermia

International Journal of Andrology

Volumn 23, Issue 6, 2000, Pages 320-331

  Adamopoulos, Dimitrios A ^a  

^a HELENA VENIZELOU HOSPITAL   (Greece)

Author keywords

Androgens; Antioestrogens; Follicle stimulating hormone; Human menopausal gonadotrophins; Idiopathic oligozoospermia; Treatment

Indexed keywords

ANDROGEN; ANTIESTROGEN; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; FOLLITROPIN; GONADORELIN; HUMAN MENOPAUSAL GONADOTROPIN; MESTEROLONE; TAMOXIFEN CITRATE; TESTOSTERONE UNDECANOATE;

EVIDENCE BASED MEDICINE; IDIOPATHIC DISEASE; INFERTILITY THERAPY; OLIGOSPERMIA; PRIORITY JOURNAL; REVIEW; SPERMATOGENESIS; SPERMATOZOON MATURATION;

CLINICAL TRIALS; HUMANS; MALE; OLIGOSPERMIA;

EID: 0033661757     PISSN: 01056263     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2605.2000.00258.x     Document Type: Review

References (72)

1. Pure human follicle stimulating hormone has a role in the treatment of severe male infertility by assisted reproduction: Norfolk's total experience
2. The effect of clomiphene citrate on sex hormone binding globulin in normospermic and oligozoospermic men
3. Hormone levels in the reproductive system of normospermic men and patients with oligospermia and varicocele
4. Endocrine effects of short term combined tamoxifen and testosterone undecanoate treatment in men
5. Endocrine effects of testosterone undecanoate as a supplementary treatment to menopausal gonadotropins or tamoxifen citrate in idiopathic oligozoospermia
6. The combination of testosterone undecanoate with tamoxifen citrate enhances the effects of each agent given independently on seminal parameters in men with idiopathic oligozoospermia
7. Androgens and spermatogenesis: Pathophysiology and testosterone herapeutic considerations
8. FSH as a therapeutic option in idiopathic oligozoospermia and male factor subfertility
9. Medical treatment of idiopathic oligozoospermia and male factor subfertility
10. Tamoxifen citrate therapy in male infertility
11. Regulation of inhibin production in the human male and its clinical application
12. Physiological relationships between inhibin B, follicle stimulating hormone secretion and spermatogenesis in normal men and response to gonadotrophin suppression by exogenous testosterone
13. The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection
14. The effect of follicle stimulating hormone therapy on human sperm structure (Notulae seminologicae II)
15. Medical treatment for idiopathic male infertility: Is it curative or palliative?
16. Spontaneous improvement in semen quality: Regression towards the mean
17. Treatment of severe male subfertility with pure follicle stimulating hormone (FSH): The need for a properly controlled multi-centre trial
18. Pulsative GnRH-therapy in oligozoospermic men does not improve seminal parametres despite decreased FSH levels
19. Diagnostic tools in male infertility
20. Sperm quality of subfertile males before and after treatment with follicle-stimulating homrone
21. Follicle stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: The impact on sperm microstructure and fertilization potential
22. Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor testolactone. Results of a double-blinded, randomized, placebo-controlled trial with crossover
23. Treatment of oligozoospermia with tamoxifen
24. Economic strategies in modern male subfertility
25. The effective cumulative pregnancy rate of different modes of treatment of male infertility
26. Expanding our understanding of spermatogenesis: The future genetic tests for infertility
27. Evidence for a stimulatory role of follicle-stimulating hormone on the spermatogonial population in adult males
28. Inhibin B plasma concentrations in oligozoospermic subjects before and after therapy with follicle stimulating hormone
29. Leydig cell function in infertile men with idiopathic oligospermic infertility
30. Leydig cell function in idiopathic oligozoospermia
31. Efficacy of kallikrein in the treatment of oligozoospermia and asthenozoospermia: A double blind trial
32. Treatment of idiopathic oligozoospermia with an alpha-blocker: A placebo-controlled double blind trial
33. Secular and seasonal changes in semen quality among young Danish men - A statistical analysis of semen samples from 1927 donor candidates during 1977-95
34. Epidemiology and aetiology of male infertility
35. The Sertoli-germ cell communication network in mammals
36. Conventional treatments of male infertility in the age of evidence-based andrology
37. Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: A randomized, double-blind, placebo-controlled, clinical trial
38. Analysis of medical treatment of male infertility
39. Sertoli cell reserve capacity in normo- and oligozoospermic men. 1st European Congress of Andrology, March 24-27, 2000, L' Aquila-Italy
40. Ineffectiveness of kallikrein in treatment of idiopathic male infertility: A double-blind, randomized, placebo-controlled trial
41. A double blind randomized placebo controlled trial using the antioxidant vitamin E to treat oxygen species associated male infertility
42. Treatment of severe oligozoospermia with hCG/hMG: A placebo-controlled, double blind trial
43. Tamoxifen treatment in male infertility. I. Effect on spermatozoa
44. Treatment of idiopathic oligozoospermia with tamoxifen - A randomized controlled study
45. Placebo controlled, double-blind, cross-over trial of glutathione therapy in male infertility
46. Treatment of the male with follicle-stimulating hormone and intra-uterine insemination with husband's spermatozoa: A randomized study
47. A prospective comparative trial of a gonadotropins-releasing hormone analogue with clomiphene citrate for the treatment of oligosthenospermia
48. Empirical therapies for male idiopathic infertility
49. Role of FSH in the regulation of spermatogenesis: Clinical aspects
50. Treatment of male infertility. Is it effective? Review and meta-analysis of published randomized controlled trials
51. Oral treatment of oligozoospermia with testosterone undecanoate: Results of a double-blind-placebo-controlled trial
52. Antioxidant treatment of patients with asthenozoospermia a moderate oligoathenozoospermia wtih high-dose Vitamin C and Vitamin E: A randomized, placebo-controlled, double blind study
53. Inhibition of angiotensin-converting enzyme - A new concept of medical treatment of male infertility?
54. The effect of clomiphene citrate and vitamin C for male infertility
55. Randomized trial of mesterolone versus vitamin C for male infertility
56. Regulation of spermatogenesis
57. FSH in therapy: Physiological basis, new preparations and clinical use
58. Paracrine factors relevant to the regulation of spermatogenesis
59. The effect of follicle-stimulating hormone on sperm quality: An ultrastructural mathematical evaluation
60. Differentiation of spermatogenic cells during in vitro culture of testicular biopsy samples from patients with obstructive azoospermia: Effect of recombinant follicle stimulating hormone
61. In-vitro spermatogenesis resumption in men with maturation arrest: Relationship with in-vivo blocking stage and serum FSH
62. Treatment of oligozoospermia with tamoxifen citrate (open and controlled studies)
63. The medical treatment of idiopathic oligo/athenospermia: Androgens (mesterolone or testosterone) versus placebo or no treatment
64. The medical treatment of oligo/athenospermia: Anti-oestrogens (clomiphene or tamoxifen) versus placebo or no treatment
65. Hormonal effect of an antiestrogen, tamoxifen, in normal and oligospennic men
66. Pulsatile LHRH therapy of 'slow pulsing oligospermia': Indirect evidence for a hypothalamic origin of the disorder
67. Mesterolone and idiopathic male infertility: A double blind study
68. A double blind trial of clomiphene citrate for the treatment of idiopathic male infertility
69. Comparison of the effectiveness of placebo and a-blocker therapy for treatment of idiopathic oligozoospermia
70. Androgens in seminal plasma: Markers of the surface epithelium of the male genital tract